OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
February 21, 2024
Challenges in fermentation can be addressed through equipment changes, facility design, and process development.
February 20, 2024
FDA has approved Iovance Biotherapeutics’ Amtagvi (lifileucel) for treating patients with unresectable or metastatic melanoma.
Webinar Date/Time: Thu, Mar 14, 2024 2:00 PM EDT
February 16, 2024
Webinar Date/Time: Wed, Mar 27, 2024 11:00 AM EDT
Managing the intricacies of sterile product development is imperative for successful and compliant outcomes.
February 15, 2024
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 12, 2024
Under the new partnership, Samsung Biologics will develop and manufacture an antibody for a LegoChem Biosciences ADC candidate.
Webinar Date/Time: Tue, Mar 5, 2024 2:00 PM EST
February 09, 2024
Webinar Date/Time: Thu, Mar 7, 2024 10:00 AM EST
February 07, 2024
Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.